LeonaBio (LONA) EBITDA (2019 - 2026)
LeonaBio (LONA) reported EBITDA of -$33.0 million for Q1 2026, down 260.26% year-over-year from $20.6 million in Q1 2025, and up 60.24% quarter-over-quarter from -$82.9 million in Q4 2025.
LeonaBio (LONA) EBITDA (2019 - 2026) Analysis & Trends
LeonaBio (LONA) has 8 years of EBITDA data on file, last reported at -$33.0 million in Q1 2026.
- EBITDA for Q1 2026 came in at -$33.0 million, down 260.26% year-over-year; the trailing twelve-month figure through Mar 2026 was -$129.4 million (down 62.57% YoY), and the FY2025 annual result was -$105.6 million, down 9.34% from the prior year.
- EBITDA improved to -$33.0 million in Q1 2026 per LONA's latest filing, from -$82.9 million in the prior quarter.
- Over five years, EBITDA peaked at -$6.6 million in Q3 2025 and troughed at -$82.9 million in Q4 2025.
- A 5-year average of -$26.4 million and a median of -$26.8 million in 2024 frame the typical range for EBITDA.
- On a YoY basis, EBITDA climbed as much as 76.97% in 2025 and fell as far as 452.42% in 2025.
- A 5-year view of EBITDA shows it stood at -$29.6 million in 2022, then grew by 8.99% to -$27.0 million in 2023, then jumped by 44.34% to -$15.0 million in 2024, then sank by 452.42% to -$82.9 million in 2025, then jumped by 60.24% to -$33.0 million in 2026.
- Business Quant data shows LONA's EBITDA at -$33.0 million in Q1 2026, -$82.9 million in Q4 2025, and -$6.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.92 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -13.63 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -752,618.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -65.83 Mn |
| 10 | LeonaBio | 154.12 Mn | 86.44 Mn | - | -32.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32.96 Mn |
| Dec 31, 2025 | -82.89 Mn |
| Sep 30, 2025 | -6.61 Mn |
| Jun 30, 2025 | -6.97 Mn |
| Mar 31, 2025 | -9.15 Mn |
| Dec 31, 2024 | -15.01 Mn |
| Sep 30, 2024 | -28.70 Mn |
| Jun 30, 2024 | -26.76 Mn |
| Mar 31, 2024 | -26.13 Mn |
| Dec 31, 2023 | -26.96 Mn |
| Sep 30, 2023 | -32.71 Mn |
| Jun 30, 2023 | -29.51 Mn |
| Mar 31, 2023 | -26.89 Mn |
| Dec 31, 2022 | -29.62 Mn |
| Sep 30, 2022 | -20.74 Mn |
| Jun 30, 2022 | -24.80 Mn |
| Mar 31, 2022 | -22.05 Mn |
| Dec 31, 2021 | -16.73 Mn |
| Sep 30, 2021 | -15.71 Mn |
| Jun 30, 2021 | -13.97 Mn |